RNASKY
LIVE

Serial Number

79400159

Owner

Miltenyi Biotec B.V. & Co. KG

Attorney

MICHELLE LEVIN

Filing Date

Jan 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

RNASKY Trademark

Serial Number: 79400159 • Registration: 7629100

RNASKY is a trademark filed by Miltenyi Biotec B.V. & Co. KG on January 19, 2024. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

Entity Type: 99

Trademark Details

Filing Date

January 19, 2024

Registration Date

December 31, 2024

Published for Opposition

November 12, 2024

Goods & Services

Chemical, biological and biochemical products for industrial, scientific purposes, namely, peptides, fluorescent dyes and conjugates thereof for use in separation processes for biological materials; reagents for cell separation; reagents for DNA, RNA, and polynucleotide detection; reagents for amplification, sequencing and detection of genetic material; reagents for Polymerase Chain Reaction (PCR); in situ polynucleotide detection reagents; in situ hybridization (ISH) reagents; fluorescence in situ hybridization (FISH) reagents; polynucleotide hybridization reagents; spatial multi-omics reagents; spatial transcriptomics reagents; polynucleotide detection probes; labeling reagents; media for cell culture for research laboratories; substances and ingredients for the preparation of media; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological material; reagents with magnetic beads; tissue staining reagents; antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, namely, imaging instruments, reagents for processing of biological material, namely, tissue, bone marrow, cells, blood other than for medical or veterinary purposes; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, and in the biotechnology industry; enzymes, other than for medical or veterinary use; polynucleotides, polynucleotide, DNA, and RNA primers and probes, fluorescence primers and probes, fluorophores, chemical additives for dyeing, all for scientific purposes; all the above for industrial or scientific purposes

Medical imaging apparatus; instruments for spatial biology; instruments for polynucleotide sequencing; instruments for amplification and detection of genetic material; instruments for tissue visualization, in situ hybridization (ISH) instruments, fluorescence in situ hybridization (FISH) instruments; Polymerase Chain Reaction (PCR) instruments; apparatus for spatial multi-omics and spatial transcriptomics; apparatus for histology, all for medical and diagnostic purposes; histopathology slides and chambers; columns for analysis for medical purposes; all the aforementioned for medical purposes; apparatus and instruments for medical purposes

Apparatus for imaging for use in the study of spatial biology imaging; Scientific laboratory research instruments for polynucleotide sequencing; scientific laboratory research instruments for amplification and detection of genetic material; scientific laboratory research instruments for tissue visualization, in situ hybridization (ISH) instruments, fluorescence in situ hybridization (FISH) instruments; Scientific apparatus, namely, for spatial multi-omics and spatial transcriptomics for use in the science industry; apparatus for histology, namely, fluorescent imaging apparatuses and microscopes all for scientific purposes; histopathology slides and chambers; all the aforesaid being for laboratory use

Primers and surgical dyes for use in pharmaceutical or scientific industries

Scientific and technological services, namely, research and design services; services for design of polynucleotide probes and genetic panels; all of the aforementioned services for and in connection with detection, localization and analysis of proteins and genetic material for biological and medical research, medical diagnostics and therapy

Nucleotides, polynucleotides, polynucleotides, namely, primers or probes for dna and rna, fluorescence primers and probes, complexes of molecules; all for medical purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 1, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 17, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 17, 2025 OPNR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 18, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 2, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 2, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 31, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 22, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 22, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 16, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 15, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 25, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 25, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 18, 2024 REPR